
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Remove Biologicals filter Biologicals (2)
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (7) Apply Prescription medicines filter
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Remove Scheduling filter Scheduling (56)
- Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA) (2)
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
- (-) Remove Biologicals filter Biologicals
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
- (-) Remove Scheduling filter Scheduling
- (-) Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA)
Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, June 2022
Closed on 27 May 2022
Notice of interim decisions on proposed amendments to the Poisons Standard – Joint ACMS-ACCS #25 - June 2020
Closed on 11 April 2022
Notice of interim decisions on proposed amendments to the Poisons Standard – ACMS #36 ACCS #32 Joint ACMS-ACCS #29 - November 2021
Closed on 11 April 2022
Priority Review pathway for biologicals: feasibility, potential eligibility criteria and determination process
Closed on 28 March 2022
Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, March 2022
Closed on 31 January 2022
Consultation on potential regulatory options for 'export only' biologicals
Closed on 20 December 2021
Discussion paper on potential for mandatory reporting of medical device adverse events by healthcare facilities in Australia
Closed on 13 December 2021
Notice of interim decisions on proposed amendments to the Poisons Standard (sodium nitrite) - June 2021
Closed on 11 November 2021
Notice of interim decisions on proposed amendments to the Poisons Standard – ACCS #31 – June 2021
Closed on 11 November 2021
Notice of interim decisions on proposed amendments to the Poisons Standard - Joint ACMS-ACCS #28 - June 2021
Closed on 11 November 2021